Malaysia has signed a COVID-19 vaccine deal with AstraZeneca. It has secured 6.4 million doses, on top of an agreement with Pfizer-BioNTech for nearly 13 million doses. This means Malaysia has enough to inoculate 40% of its population. Prime Minister Muhyiddin Yassin said final talks are underway with other vaccine makers, including China's Sinovac and Russia's Gamaleya. The first batch of Pfizer vaccines is expected to arrive in February 2021.

Subscribe to our channel here: [ Ссылка ]

Subscribe to our news service on Telegram: [ Ссылка ]

Follow us:
CNA: [ Ссылка ]
CNA Lifestyle: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]

свернуть